Biomedix Financial Statements From 2010 to 2024
| BMDX Stock | ILS 19,200 480.00 2.56% |
Check Biomedix Incubator financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biomedix Incubator's main balance sheet or income statement drivers, such as , as well as many indicators such as . Biomedix financial statements analysis is a perfect complement when working with Biomedix Incubator Valuation or Volatility modules.
Biomedix |
Biomedix Incubator Company Shares Outstanding Analysis
Biomedix Incubator's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Biomedix Incubator Shares Outstanding | 2.07 M |
Most of Biomedix Incubator's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biomedix Incubator is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Biomedix Incubator has 2.07 M of shares currently outstending. This is much higher than that of the sector and significantly higher than that of the Shares Outstanding industry. The shares outstanding for all Israel stocks is notably lower than that of the firm.
Biomedix Incubator Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biomedix Incubator's current stock value. Our valuation model uses many indicators to compare Biomedix Incubator value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biomedix Incubator competition to find correlations between indicators driving Biomedix Incubator's intrinsic value. More Info.Biomedix Incubator is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biomedix Incubator by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biomedix Incubator's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Biomedix Incubator Financial Statements
Biomedix Incubator stakeholders use historical fundamental indicators, such as Biomedix Incubator's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biomedix Incubator investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biomedix Incubator's assets and liabilities are reflected in the revenues and expenses on Biomedix Incubator's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biomedix Incubator. Please read more on our technical analysis and fundamental analysis pages.
Biomedix Incubator Ltd is a venture capital firm and accelerator specializing in start-up and incubation investments. Biomedix Incubator Ltd. was founded in 2000 and is based in Ramat Gan, Israel with an additional office in New York, New York. Biomedix Incubator is traded on Tel Aviv Stock Exchange in Israel.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biomedix Stock
Biomedix Incubator financial ratios help investors to determine whether Biomedix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biomedix with respect to the benefits of owning Biomedix Incubator security.